Ignite Creation Date:
2025-12-26 @ 12:16 PM
Ignite Modification Date:
2026-06-03 @ 6:57 AM
Study NCT ID:
NCT01329900
Status:
COMPLETED
Last Update Posted:
2020-07-08
First Post:
2011-04-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Chemotherapy Plus Ofatumumab Followed by G-CSF for Mobilization of Peripheral Blood Stem Cells in Patients With Non-Hodgkin's Lymphomas
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Lymphoma | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Chemotherapy | View |
| None | Stem Cell Collection | View |
| None | Ofatumumab | View |
| None | Arzerra | View |
| None | Ifosfamide | View |
| None | Ifex | View |
| None | Etoposide | View |
| None | VePesid | View |
| None | Mesna | View |
| None | Mesnex | View |
| None | G-CSF | View |
| None | Filgrastim | View |
| None | Neupogen | View |
| None | Apheresis | View |